Literature DB >> 12943956

Primary insomnia: a risk factor to develop depression?

Dieter Riemann1, Ulrich Voderholzer.   

Abstract

BACKGROUND: Chronic insomnia afflicts approximately 5-10% of the adult population in Western industrialized countries. Insomnia may be secondary, i.e. triggered and/or maintained by psychiatric/organic illnesses, the intake of prescribed/illicit drugs or alcohol, or by a combination of these factors. Insomnia can also occur as primary insomnia, caused by a psychophysiological hyperarousal process. In the present review a literature search was undertaken to identify longitudinal epidemiological studies which investigate the question whether primary insomnia at baseline predicts the development of depression at follow-up measurements.
METHODS: MEDLINE search for the medical subject headings insomnia and depression; identification of longitudinal epidemiological studies with at least two measurement points 1 year apart measuring insomnia and depression and indicating explicit criteria for both disorders.
RESULTS: Eight relevant epidemiological studies were identified. Almost unambiguously insomnia at baseline significantly predicted an increased depression risk at follow-up 1-3 years later.
CONCLUSION: As insomniac symptoms alone seem to be of predictive value for the development of depression in the succeeding years, it would be worthwhile to investigate if early adequate treatment is able to prevent psychiatric sequelae of primary insomnia.

Entities:  

Mesh:

Year:  2003        PMID: 12943956     DOI: 10.1016/s0165-0327(02)00072-1

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  182 in total

1.  Sleep Disturbances in Pediatric Depression.

Authors:  Uma Rao
Journal:  Asian J Psychiatr       Date:  2011-12

2.  Circadian activity rhythms and mortality: the study of osteoporotic fractures.

Authors:  Gregory J Tranah; Terri Blackwell; Sonia Ancoli-Israel; Misti L Paudel; Kristine E Ensrud; Jane A Cauley; Susan Redline; Teresa A Hillier; Steven R Cummings; Katie L Stone
Journal:  J Am Geriatr Soc       Date:  2010-01-26       Impact factor: 5.562

3.  Pharmacological Treatment of Insomnia.

Authors:  Janette D Lie; Kristie N Tu; Diana D Shen; Bonnie M Wong
Journal:  P T       Date:  2015-11

4.  Pre-deployment insomnia is associated with post-deployment post-traumatic stress disorder and suicidal ideation in US Army soldiers.

Authors:  Hohui E Wang; Laura Campbell-Sills; Ronald C Kessler; Xiaoying Sun; Steven G Heeringa; Matthew K Nock; Robert J Ursano; Sonia Jain; Murray B Stein
Journal:  Sleep       Date:  2019-02-01       Impact factor: 5.849

5.  The direction of longitudinal associations between sleep problems and depression symptoms: a study of twins aged 8 and 10 years.

Authors:  Alice M Gregory; Frühling V Rijsdijk; Jennifer Y F Lau; Ronald E Dahl; Thalia C Eley
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

6.  Sleep Related Cognitions in Individuals with Symptoms of Insomnia and Depression.

Authors:  Jessica C Levenson; Ruth M Benca; Meredith E Rumble
Journal:  J Clin Sleep Med       Date:  2015-08-15       Impact factor: 4.062

7.  Vulnerability to Stress-Related Sleep Disturbance and Insomnia: Investigating the Link with Comorbid Depressive Symptoms.

Authors:  Ivan Vargas; Naomi P Friedman; Christopher L Drake
Journal:  Transl Issues Psychol Sci       Date:  2015-03-01

8.  Restless Legs Syndrome and Depression: Effect Mediation by Disturbed Sleep and Periodic Limb Movements.

Authors:  Brian B Koo; Terri Blackwell; Hochang B Lee; Katie L Stone; Elan D Louis; Susan Redline
Journal:  Am J Geriatr Psychiatry       Date:  2016-04-27       Impact factor: 4.105

9.  Prevalence, course, and comorbidity of insomnia and depression in young adults.

Authors:  Daniel J Buysse; Jules Angst; Alex Gamma; Vladeta Ajdacic; Dominique Eich; Wulf Rössler
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

10.  [Disturbances of slow-wave sleep and psychiatric disorders].

Authors:  J P Doerr; V Hirscher; D Riemann; U Voderholzer
Journal:  Nervenarzt       Date:  2010-03       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.